Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 06:11 am Purchase |
2021-12-31 | 13G | Galera Therapeutics, Inc. GRTX |
Blackstone Holdings I/II GP L.L.C. | 1,706,408 6.400% |
19,184 (+1.14%) |
Filing History |
| 2022-02-10 08:48 am Sale |
2021-12-31 | 13G | Galera Therapeutics, Inc. GRTX |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
-1,509,500 (Position Closed) |
Filing History |
| 2022-02-02 4:55 pm Sale |
2021-12-31 | 13G | Galera Therapeutics, Inc. GRTX |
Novo Holdings A/S | 2,459,021 9.300% |
-500,000 (-16.90%) |
Filing History |
| 2021-12-27 4:12 pm Purchase |
2021-12-14 | 13G | Galera Therapeutics, Inc. GRTX |
Citadel Advisors LLC | 171,733 0.600% |
171,733 (New Position) |
Filing History |
| 2021-10-20 3:42 pm Sale |
2021-10-19 | 13G | Galera Therapeutics, Inc. GRTX |
HIRSCHMAN ORIN | 0 0.000% |
-2,095,291 (Position Closed) |
Filing History |
| 2021-06-07 06:18 am Purchase |
2021-05-24 | 13G | Galera Therapeutics, Inc. GRTX |
HIRSCHMAN ORIN | 2,095,291 11.000% |
358,969 (+20.67%) |
Filing History |
| 2021-04-29 6:19 pm Purchase |
2021-04-29 | 13G | Galera Therapeutics, Inc. GRTX |
HIRSCHMAN ORIN | 1,736,322 11.000% |
1,736,322 (New Position) |
Filing History |
| 2021-02-16 5:01 pm Purchase |
2020-12-31 | 13G | Galera Therapeutics, Inc. GRTX |
Blackstone Holdings I/II GP L.L.C. | 1,687,224 6.800% |
1,687,224 (New Position) |
Filing History |
| 2021-02-16 4:08 pm Sale |
2020-12-31 | 13G | Galera Therapeutics, Inc. GRTX |
Venrock Healthcare Capital Partners III L.P. | 917,860 3.700% |
-825,528 (-47.35%) |
Filing History |
| 2021-02-11 07:45 am Purchase |
2020-12-31 | 13G | Galera Therapeutics, Inc. GRTX |
ADAGE CAPITAL PARTNERS GP LLC | 1,509,500 6.050% |
209,500 (+16.12%) |
Filing History |
| 2021-02-08 4:58 pm Sale |
2020-12-31 | 13G | Galera Therapeutics, Inc. GRTX |
Novo Holdings A/S | 2,959,021 11.900% |
-450,000 (-13.20%) |
Filing History |
| 2021-02-01 3:50 pm Sale |
2020-12-31 | 13G | Galera Therapeutics, Inc. GRTX |
Novartis Bioventures Ltd | 2,467,960 9.890% |
-1,075,107 (-30.34%) |
Filing History |
| 2020-11-04 4:52 pm Purchase |
2020-10-16 | 13G | Galera Therapeutics, Inc. GRTX |
Venrock Healthcare Capital Partners III L.P. | 1,743,388 7.000% |
1,743,388 (New Position) |
Filing History |